1. ScholarBank@NUS

Koh Chee Liang, Stephen

rp01431

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Koh Chee Liang, Stephen
(not current staff)
Variants
Koh, S.C.L.
Kohsc, L.
Kohcl, S.
Koh, C.L.S.
Koh, C.S.
Koh, S.C.
Koh, S.
 
Main Affiliation
 
Faculty
 
Email
obgkohcl@nus.edu.sg
 

Publications

Results 21-40 of 45 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
212005Hemostatic status and fibrinolytic response potential at different phases of the menstrual cycleKoh, S.C.L. ; Prasad, R.N.V. ; Fong, Y.F. 
22Nov-1994Influence of circulating D-dimer levels on assays of fibrinogen.Koh, S.C. ; Chew, C.Y.; Viegas, O.A. ; Choo, M. ; Ratnam, S.S. 
23May-1996Levels of lupus autoantibodies in pregnant SLE patients: Correlations with disease activity and pregnancy outcomeTomer, Y.; Viegas, O.A.C. ; Swissa, M.; Koh, S.C.L. ; Shoenfeld, Y.
241996Levels of lupus autoantibodies in pregnant SLE patients: Correlations with disease activity and pregnancy outcomeTomer, Y.; Swissa, M.; Shoenfeld, Y.; Viegas, O.A.C. ; Koh, S.C.L. 
251992Plasma urokinase activity and antigen levels in normal males, females and in late pregnancyKoh, S.C.L. ; Yuen, R. ; Viegas, O.A.C. ; Ratnam, S.S. 
261992Plasminogen activators and inhibitors in normal late pregnancy, postpartum and in the postnatal periodKoh, C.L.S. ; Viegas, O.A.C. ; Yuen, R. ; Chua, S.E.; Ng, B.L.; Ratnam, S.S. 
271996Plasminogen activators and inhibitors, D-dimer and β-TG in systemic lupus erythematosus pregnancy in relation to their obstetric outcomeKoh, S.C.L. ; Boey, M.L.; Ratnam, S.S. ; Viegas, O.A.C. 
281987Plasminogen activators in the endometrium; a preliminary study in subfertile subjectsKoh, S.C.L. ; Wong, P.C.; Yuen, R. 
291987Plasminogen activators in the endometrium; a preliminary study in subfertile subjectsKoh, S.C.L. ; Wong, P.C. ; Yuen, R. 
301991Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and femalesKoh, S.C.L. ; Yuen, R. ; Viegas, O.A.C. ; Chua, S.E. ; Ng, B.L. ; Sen, D.K. ; Ratnam, S.S. 
311993Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsiaKoh, S.C.L. ; Anandakumar, C. ; Montan, S. ; Ratnam, S.S. 
321998Preeclampsia: Haemostatic status and the short-term effects of methyldopa and isradipine therapyYin, K.H.; Koh, S.C.L. ; Biswas, A. ; Arulkumaran, S. ; Ratnam, S.S. ; Malcus, P.; SvenMontan, S.
331998Preliminary study of uPAR and plasminogen activators and inhibitors in tissues from benign and ovarian cancerKohsc, L. ; Tham, K.F. ; Razvik, L.; Oe, P.L. 
342006The association between fibrinogen, von Willebrand Factor, antithrombin III, and D-dimer levels and survival outcome by 36 months from ovarian cancerKoh, S.C.L. ; Khalil, R.; Lim, F.-K.; Ilancheran, A. ; Choolani, M. 
352007The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagiaKoh, S.C.L. ; Singh, K. 
361980The effect of long-term steroid contraception on coagulation in Asian womenTsakok, F.H.M.; Ho, L.M.; Koh, S. ; Ratnam, S.S. 
371988The effect of Norplant®-2 rods on clinical chemistry in Singaporean acceptors after 1 year of use: Haemostatic changesSingh, K. ; Viegas, O.A.C. ; Koh, S. ; Singh, P. ; Ratman, S.S. 
381995The effects of gynaecological surgery on coagulation activation, fibrinolysis and fibrinolytic inhibitor in patients with and without ketorolac infusionKoh, S.C.L. ; Pua, H.L.; Ratnam, S.S. ; Tay, D.H.B.
391998The effects of long-term hormone-replacement therapy on coagulation, fibrinolysis and inhibitors in postmenopausal womenKoh, S.C.L. ; Dramusic, V. ; Shan, Ratnam S. 
401988The effects of Norplant® on clinical chemistry in Singaporean acceptors after 1 year of use: I. Haemostatic changesViegas, O.A.C. ; Singh, K. ; Koh, S. ; Singh, P. ; Ratnam, S.S.